Maintenance fees coming due

BioAtla Inc.

9 maintenance fees come due in the 12 months from Nov 14, 2026, the next on Dec 25, 2026. Unpaid by Jun 25, 2027, that one lapses early.

A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.

Patent	Title	Holder	Status	Fee due	Lapses if unpaid	Expires	Confidence
US 10,329,556	Conditionally Active Biological Proteins BioAtla, Inc. In force Fee due Dec 25, 2026 Lapses if unpaid Jun 25, 2027 Term ends May 16, 2035 · High confidence	BioAtla, Inc.	In force	Dec 25, 2026	Jun 25, 2027	Term ends May 16, 2035	High confidence
US 11,718,844	Mirac Proteins BioAtla, Inc. In force Fee due Feb 8, 2027 Lapses if unpaid Aug 9, 2027 Term ends Mar 9, 2030 · High confidence	BioAtla, Inc.	In force	Feb 8, 2027	Aug 9, 2027	Term ends Mar 9, 2030	High confidence
US 11,773,509	Conditionally Active Polypeptides and Methods of Generating Them BioAtla, Inc. In force Fee due Apr 3, 2027 Lapses if unpaid Oct 4, 2027 Term ends Feb 7, 2038 · High confidence	BioAtla, Inc.	In force	Apr 3, 2027	Oct 4, 2027	Term ends Feb 7, 2038	High confidence
US 11,834,472	Anti-Il-22 Antibodies, Antibody Fragments,Their Immunoconjugates And Uses Thereof BioAtla, Inc. In force Fee due Jun 5, 2027 Lapses if unpaid Dec 6, 2027 Term ends Oct 10, 2039 · High confidence	BioAtla, Inc.	In force	Jun 5, 2027	Dec 6, 2027	Term ends Oct 10, 2039	High confidence
US 10,513,699	Discovering and Producing Conditionally Active Biologic Proteins in the Same Eukaryotic Cell Production Hosts BioAtla, Inc. In force Fee due Jun 24, 2027 Lapses if unpaid Dec 27, 2027 Term ends Jan 14, 2036 · High confidence	BioAtla, Inc.	In force	Jun 24, 2027	Dec 27, 2027	Term ends Jan 14, 2036	High confidence
US 11,851,499	Conditionally Active Anti-Epcam Antibodies, Antibody Fragments, Their Immunoconjugates and Uses Thereof BioAtla, Inc. In force Fee due Jun 26, 2027 Lapses if unpaid Dec 27, 2027 Ends no later than Jun 10, 2040 · Medium confidence	BioAtla, Inc.	In force	Jun 26, 2027	Dec 27, 2027	Ends no later than Jun 10, 2040	Medium confidence
US 11,897,959	Anti-Axl Antibodies, Antibody Fragments and Their Immunoconjugates and Uses Thereof BioAtla, Inc. In force Fee due Aug 13, 2027 Lapses if unpaid Feb 14, 2028 Ends no later than Sep 26, 2037 · Medium confidence	BioAtla, Inc.	In force	Aug 13, 2027	Feb 14, 2028	Ends no later than Sep 26, 2037	Medium confidence
US 10,562,981	Express Humanization of Antibodies BioAtla, Inc. In force Fee due Aug 18, 2027 Lapses if unpaid Feb 18, 2028 Ends no later than Dec 28, 2031 · Low confidence	BioAtla, Inc.	In force	Aug 18, 2027	Feb 18, 2028	Ends no later than Dec 28, 2031	Low confidence
US 10,563,194	Conditionally Active Biological Proteins BioAtla, Inc. In force Fee due Aug 18, 2027 Lapses if unpaid Feb 18, 2028 Term ends Jun 22, 2036 · High confidence	BioAtla, Inc.	In force	Aug 18, 2027	Feb 18, 2028	Term ends Jun 22, 2036	High confidence

9 of 9 patents shown. Soonest fee due date first, then patent number.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.